KRAS and pancreatic ductal adenocarcinoma: Hence, to identify the crucial biomarkers involved in the sotorasib resistance, we have retrieved the RNA-seq data from the NCBI GEO database of AMG 510 treated (resistant) and untreated in KRAS G12C-mutant MIA-PaCa2 pancreatic ductal adenocarcinoma cells.